David Kerstein

Insider Reports History

Location
Jerusalem, Israel
Signature
/s/ Bradford Dahms - Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Kerstein:

Company Role Class Num Shares Value Price $ Report Date Ownership
Theseus Pharmaceuticals, Inc. Chief Medical Officer Restricted Stock Units 17,500 $53,375 $3.05 01 Mar 2023 Direct

Insider Reports Filed by David Kerstein

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000110465923027625-kerstein-david-2023-03-01 Theseus Pharmaceuticals, Inc. 01 Mar 2023 1 $0 4 Chief Medical Officer 02 Mar 2023, 06:01
/report/000110465923023507-kerstein-david-2023-02-17 Theseus Pharmaceuticals, Inc. 17 Feb 2023 1 $0 4 Chief Medical Officer 21 Feb 2023, 06:03
/report/000089924322007501-kerstein-david-2022-02-18 Theseus Pharmaceuticals, Inc. 18 Feb 2022 1 $0 4 Chief Medical Officer 23 Feb 2022, 19:00
/report/000089924321039504-kerstein-david-2021-10-06 Theseus Pharmaceuticals, Inc. 06 Oct 2021 0 $0 3 Chief Medical Officer 06 Oct 2021, 19:00